Amarin Corp Plc (AMRN)

[Biobillionair]

STS-

Only thing I worry about is FDA banning synthetic EPA DS before R-IT results are out, and that's the only thing any sane person would be concerned about, assuming R-IT is a success.

First, FDA will not ban synthetics; if anything the could determine GRAS at certain dose.

Second, the longer Amarin ANCHOR & R-I patents are shielded from the Orange Book the weaker they get. The patents can only be submitted after sNDA or NDA 30 day window timeframe.

Finally, a patent loss regarding just the OB Marine patents prior to adding ANCHOR or R-I patents creates a carve out that cannot enforce just Vascepa R-I sales.

There’s a reason why only the uninformed on this board are excited about mid 2018 results and maybe a label by the end of 2019. Time for a successful R-I launch is going very fast and Amarin will launch with 1/2 the sales force due to 2013 lay off.

This board is not seeing truth.

BB